Similar articles

• Time to lower treatment BP targets for hypertension?

  Carlberg B. Carlberg B. Lancet. 2009 Aug 15;374(9689):503-4. doi: 10.1016/S0140-6736(09)61467-7. Lancet. 2009. PMID: 19683626 No abstract available.
• A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials.

  Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP. Pocock SJ, et al. BMJ. 2001 Jul 14;323(7304):75-81. doi: 10.1136/bmj.323.7304.75. BMJ. 2001. PMID: 11451781 Free PMC article.
• From the Editor.

  Levy D. Levy D. J Am Soc Hypertens. 2017 Mar;11(3):131. doi: 10.1016/j.jash.2017.01.005. Epub 2017 Feb 2. J Am Soc Hypertens. 2017. PMID: 28454770 No abstract available.
• The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

  Thomas GN, Chan P, Tomlinson B. Thomas GN, et al. Drugs Aging. 2006;23(2):131-55. doi: 10.2165/00002512-200623020-00004. Drugs Aging. 2006. PMID: 16536636 Review.
• [Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension].

  Tomov I. Tomov I. Vutr Boles. 1985;24(6):39-47. Vutr Boles. 1985. PMID: 3913145 Review. Bulgarian. No abstract available.